Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Lipopolysaccharide- and paclitaxel (Taxol)-induced tolerance in murine peritoneal macrophages

View through CrossRef
LPS-tolerance, a state of refractoriness to LPS-stimulation, is induced in murine peritoneal macrophages by prior exposure to LPS. LPS-induced expression of TNF and IL-6 mRNA as well as activation of various intracellular kinases and factors, including ERK, p38, JNK, Raf-1 and NF-κB were all suppressed in LPS-tolerant macrophages; responses to stimulation by paclitaxel (Taxol™), an LPS agonist, were similarly suppressed, but responses to phorbol esters (PMA) were unaffected. Binding and uptake of [125I]-labeled LPS to tolerant macrophages was somewhat greater in tolerant than in non-tolerant macrophages. Thus, the refractory state appears to involve inhibition or blockade of LPS-signaling molecules located downstream of the cell membrane LPS receptor and upstream of the branch point in the intracellular cascades leading to activation of MAPK and NFκB. LPS conditioning also suppressed LPS- and Taxol-induced TNF production, but augmented nitric oxide (NO) production. In contrast, Taxol conditioning failed to suppress LPS-induced TNF production. Conditioning with the synthetic taxoid analog, nor-seco-taxoid, which does not induce macrophage activation, enhanced LPS- and Taxol-induced NO production. These findings provide us with new information about the relationship between the LPS and Taxol receptors as well as about the signaling pathways leading to TNF and NO production.
Title: Lipopolysaccharide- and paclitaxel (Taxol)-induced tolerance in murine peritoneal macrophages
Description:
LPS-tolerance, a state of refractoriness to LPS-stimulation, is induced in murine peritoneal macrophages by prior exposure to LPS.
LPS-induced expression of TNF and IL-6 mRNA as well as activation of various intracellular kinases and factors, including ERK, p38, JNK, Raf-1 and NF-κB were all suppressed in LPS-tolerant macrophages; responses to stimulation by paclitaxel (Taxol™), an LPS agonist, were similarly suppressed, but responses to phorbol esters (PMA) were unaffected.
Binding and uptake of [125I]-labeled LPS to tolerant macrophages was somewhat greater in tolerant than in non-tolerant macrophages.
Thus, the refractory state appears to involve inhibition or blockade of LPS-signaling molecules located downstream of the cell membrane LPS receptor and upstream of the branch point in the intracellular cascades leading to activation of MAPK and NFκB.
LPS conditioning also suppressed LPS- and Taxol-induced TNF production, but augmented nitric oxide (NO) production.
In contrast, Taxol conditioning failed to suppress LPS-induced TNF production.
Conditioning with the synthetic taxoid analog, nor-seco-taxoid, which does not induce macrophage activation, enhanced LPS- and Taxol-induced NO production.
These findings provide us with new information about the relationship between the LPS and Taxol receptors as well as about the signaling pathways leading to TNF and NO production.

Related Results

Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel
Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel
Abstract INTRODUCTION: Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and is typified by poor outcomes. G...
Abstract 1809: Reversal of Taxol resistance in ovarian cancer cell lines by IGF pathway inhibition
Abstract 1809: Reversal of Taxol resistance in ovarian cancer cell lines by IGF pathway inhibition
Abstract Our group recently reported increased insulin-like growth factor 2 (IGF2) expression and AKT activation in ovarian cancer cells following treatment with the...
Abstract B14: A novel strategy for the treatment of melanoma
Abstract B14: A novel strategy for the treatment of melanoma
Abstract Introduction: Approximately 76,000 individuals are diagnosed with melanoma, and about 9,000 die as a result of the disease each year in the United States. E...
Abstract B140: Autologous human growing tumor model and its immunological relevance for cancer immunology research
Abstract B140: Autologous human growing tumor model and its immunological relevance for cancer immunology research
Abstract Background: Tumors grow in accordance with immunoediting. If we can see the changes of immune characteristics in the microenvironment during tumor growth, w...
A Taxane Total Cost of Care Analysis in Metastatic Breast Cancer: Results of Private Payor Claims Data.
A Taxane Total Cost of Care Analysis in Metastatic Breast Cancer: Results of Private Payor Claims Data.
Abstract Background: It has been estimated that over $8 billion is spent annually on the management of breast cancer in the US. The taxane chemotherapeutic agents ar...

Back to Top